GAMMA Investing »

CanFite Biopharma shares owned by GAMMA Investing

Quarter-by-quarter ownership of CanFite Biopharma (CANF) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in CanFite Biopharma

Tip: Access up to 7 years of quarterly data

All positions including CanFite Biopharma held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in CanFite Biopharma by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2026-09-30 $15k 6.7k 2.20

More positions owned by GAMMA Investing

Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Amazon Common Stock (AMZN)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Meta Platforms Inc Cl A Common Stock (META)
Jpmorgan Chase Common Stock (JPM)
Micron Technology Common Stock (MU)
Eli Lilly Common Stock (LLY)
Advanced Micro Devices Common Stock (AMD)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
Tesla Common Stock (TSLA)

View all positions for GAMMA Investing

Top funds holding CanFite Biopharma

Citadel Advisors
Rhumbline Advisers
GAMMA Investing
Fifth Third Bancorp
Wells Fargo & Company
Activest Wealth Management
Efficient Wealth Management
Mercer Global Advisors
TD Waterhouse Canada

View all funds holding CanFite Biopharma